The use of biologics for uveitis associated with spondyloarthritis

S Arepalli, JT Rosenbaum - Current opinion in rheumatology, 2019 - journals.lww.com
The use of biologics for uveitis associated with spondyloart... : Current Opinion in
Rheumatology The use of biologics for uveitis associated with spondyloarthritis : Current …

Certolizumab Pegol treatment in patients with axial-Spondyloarthritis-associated acute anterior uveitis: a narrative review

IE van der Horst-Bruinsma, PC Robinson… - Rheumatology and …, 2022 - Springer
Background Acute anterior uveitis (AAU) affects up to 40% of patients with axial
spondyloarthritis (axSpA). An effective treatment for patients with axSpA that reduces the risk …

Integrating the pathogenesis of spondyloarthritis: gut and joint united?

K De Wilde, K Debusschere, S Beeckman… - Current opinion in …, 2015 - journals.lww.com
A significant amount of data all point in the direction of arthritis and gut inflammation being
pathogenetically closely linked in the SpA concept. However, when it comes to therapeutic …

[PDF][PDF] Management of uveitis in spondyloarthropathy: current trends

N Gupta, A Agarwal - The Permanente Journal, 2018 - thepermanentejournal.org
Spondyloarthritis is a chronic inflammatory disease predominantly affecting joints of the axial
skeleton. However, as many as 50% of patients with this disease may have extra-articular …

Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study

DR Annunciato, TL Oliveira, VO Magalhães… - Advances in …, 2023 - SciELO Brasil
Background The extra-musculoskeletal manifestations (EMMs) such as recurrent acute
anterior uveitis (rAAU), psoriasis (Ps), and inflammatory bowel disease (IBD), are related to …

An Overview to ankylosing spondylitis and spondyloarthropathies

S Assadiasl, N Soleimanifar - Ankylosing Spondylitis-Axial …, 2021 - Springer
Spondyloarthropathies (SpAs) are a debilitating group of chronic autoimmune diseases that
affect a considerable proportion of young adults causing medical, social, and economical …

Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

M Steiner, M del Mar Esteban-Ortega… - JCR: Journal of …, 2020 - journals.lww.com
Objective Choroidal thickness (CT) has been evaluated as a marker of systemic
inflammation in ankylosing spondylitis (AS). This study evaluates the CT of AS patients …

[引用][C] Extra-Articular Manifestations of Spondyloarthritis

SG Quintero, C Romero-Sánchez - 2016